Latest Articles
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)
Published: May 12, 2026, 7:56 p.m.
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care
Published: May 12, 2026, 7:56 p.m.
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)
Published: May 12, 2026, 7:52 p.m.
GLP-1–Progestin and Endometrial Cancer Risk - Conexiant
GLP-1–Progestin and Endometrial Cancer Risk Conexiant
Published: March 2, 2026, 5:01 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal
Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally
Published: Feb. 18, 2026, noon
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues
Published: Feb. 17, 2026, 3:15 p.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Published: Feb. 17, 2026, 12:15 a.m.
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com
Published: Feb. 16, 2026, 10:55 a.m.
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com
Published: Feb. 16, 2026, 6:10 a.m.
Link copied to clipboard!